Doceree Appoints Former GoodRx Executive Andrew Matthews as SVP, Patient Affordability to Scale co-pay.com [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
March 3, 2026 /PRNewswire/ -- Doceree, the world's first AI-powered Operating System for healthcare marketing, today announced the appointment of Andrew Matthews, formerly Vice President, Business Development at GoodRx, as Senior Vice President, Patient Affordability. In this role, Matthews will lead strategic growth and commercialization initiatives for co-pay.com -- Doceree's affordability platform purpose-built to activate co-pay benefits at the point of prescribing. Doceree Appoints Former GoodRx Executive Andrew Matthews as SVP, Patient Affordability to Scale co-pay.com (PRNewsfoto/Doceree) The appointment reflects Doceree's accelerating investment in patient affordability as a core strategic pillar. Unlike consumer-facing affordability platforms, co-pay.com operates within physician engagement environments -- closing the gap between co-pay program awareness and actual patient benefit activation. Matthews' experience scaling digital affordability programs at one of the countr
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- GoodRx (GDRX) had its price target lowered by Citigroup Inc. from $4.50 to $3.50. They now have a "buy" rating on the stock.MarketBeat
- GoodRx (GDRX) had its price target lowered by The Goldman Sachs Group, Inc. from $4.00 to $2.50. They now have a "neutral" rating on the stock.MarketBeat
- Why GoodRx (GDRX) Is Down 19.4% After Unveiling Employer Direct And 2026 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
- Action 9: Ways to save more on your meds [Yahoo! Finance]Yahoo! Finance
- GoodRx (GDRX) had its price target lowered by Mizuho from $4.00 to $3.00. They now have a "neutral" rating on the stock.MarketBeat
GDRX
Earnings
- 2/25/26 - Beat
GDRX
Sec Filings
- 2/27/26 - Form 8-K
- 2/26/26 - Form S-8
- 2/26/26 - Form 10-K
- GDRX's page on the SEC website